返回成功案例
医疗健康

Intergrin has raised financing provided by Kartesia

Intergrin has obtained a unitranche loan of approximately US$59 million to refinance existing debt and to further support the growth of different healthcare and well-being initiatives.

Intergrin is a Dutch healthcare provider that operates clinics focused on specialized mental healthcare through its two brands, Het Rughuis and PHI. The company is headquartered in Geleen and currently has twelve treatment locations across the south of the country. Het Rughuis provides psychosomatic treatments to individuals with spine-related pain disorders through a combination of expert cognitive behavioral therapy, lifestyle-as-a-medicine therapy, vitality and physical therapy. PHI offers specialized psychosomatic mental healthcare to those suffering from anxiety, depression, somatoform disorder and serious unexplained physical complaints. Intergrin has unrivalled high success rates and delivers sustainable results, thereby significantly improving the quality of life of patients while also lowering the medical costs to society.

The loan was provided by Kartesia, a pan-European, independent and privately owned specialist provider of financing solutions, focused on offering customized resources across the capital structure to leading mid-market companies from a wide range of industries, with the view to accelerate their pace of growth.

Oaklins’ debt advisory team in the Netherlands advised Intergrin in this transaction and assisted in establishing a financing package aligned with the current business profile and future growth ambitions. This transaction emphasizes Oaklins’ strong track record in the healthcare clinics sector, which previously included deals such as Tandarts Today, Curious Kids and Dutch Dental Group.

“We are very pleased with our partnership with Kartesia. It enables us to pursue our ambitious goals, within the Netherlands and in international markets. We will refine our treatment methodology even further and we will invest in HealthTech applications. With these funds we will be able to help many patients who suffer from severe health disorders.”

Ron Joosten and Marc Kuijpers

Founders, Intergrin

联系交易团队

Bas Stoetzer

合伙人
阿姆斯特丹, 荷兰
Oaklins Netherlands

Robert Boersma

合伙人
阿姆斯特丹, 荷兰
Oaklins Netherlands

Casper Oude Essink

总监
阿姆斯特丹, 荷兰
Oaklins Netherlands

Niels Vermuë

副总监
阿姆斯特丹, 荷兰
Oaklins Netherlands

相关交易

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
医疗健康

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

更多信息
Afric Phar has been acquired by Pharma Capital
医疗健康

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

更多信息
Xiel Limited has been acquired by MIS Healthcare
私募基金 | 医疗健康

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

更多信息